BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18971217)

  • 1. Expression profiles of the glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors.
    Costa MH; Latronico AC; Martin RM; Barbosa AS; Almeida MQ; Lotfi CF; Valassi HP; Nishi MY; Lucon AM; Siqueira SA; Zerbini MC; Carvalho LR; Mendonca BB; Fragoso MC
    J Endocrinol; 2009 Feb; 200(2):167-75. PubMed ID: 18971217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of glucose-dependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia.
    Costa MH; Domenice S; Latronico AC; Martin RM; Nishi MY; Lucon AM; Mendonca BB; Fragoso MC
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):326-31. PubMed ID: 19578593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
    Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of childhood adrenocortical tumors.
    West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
    Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
    Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis.
    Reincke M; Beuschlein F; Lalli E; Arlt W; Vay S; Sassone-Corsi P; Allolio B
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2597-600. PubMed ID: 9661652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
    Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
    Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors.
    Barzon L; Chilosi M; Fallo F; Martignoni G; Montagna L; Palù G; Boscaro M
    Eur J Endocrinol; 2001 Aug; 145(2):207-12. PubMed ID: 11454518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.
    de Sousa GR; Soares IC; Faria AM; Domingues VB; Wakamatsu A; Lerario AM; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Horm Metab Res; 2015 Aug; 47(9):656-61. PubMed ID: 25985323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin as a marker in the classification of adrenocortical tumors.
    Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
    Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
    Beuschlein F; Schulze E; Mora P; Gensheimer HP; Maser-Gluth C; Allolio B; Reincke M
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2585-8. PubMed ID: 9661649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
    Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
    Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.
    Zhao J; Speel EJ; Muletta-Feurer S; Rütimann K; Saremaslani P; Roth J; Heitz PU; Komminoth P
    Am J Pathol; 1999 Oct; 155(4):1039-45. PubMed ID: 10514385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in adrenocortical neoplasia.
    Assie G; Giordano TJ; Bertherat J
    Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.